PTC Therapeutics Inc
PTCT
Market Cap$3.95B
Close$
$29.89
38.8% downside
Current Fair Value
38.8% downsideOvervalued by 38.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.95 Billion |
|---|---|
| Enterprise Value | $2.94 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.73 |
| Beta | 0.51 |
| Outstanding Shares | 78,115,836 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 6.55 |
|---|---|
| PEG | -0.63 |
| Price to Sales | 2.33 |
| Price to Book Ratio | -16.28 |
| Enterprise Value to Revenue | 1.72 |
| Enterprise Value to EBIT | 3.61 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | -2.51 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About PTC Therapeutics Inc
CEO: Stuart Peltz